The Changing Risk Factor Profile of Participants Enrolled in a Secondary Stroke Prevention Trial: Vitamin Intervention for Stroke Prevention

Publisher： Karger

E-ISSN： 1423-0208|27|4|222-229

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.27, Iss.4, 2006-12, pp. : 222-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin Intervention for Stroke Prevention (VISP) Trial: Rationale and Design

By  

Neuroepidemiology, Vol. 20, Iss. 1, 2001-02 ,pp. : 16-25

Karger

Access to resources Recommend Favorite

Plasma Total Homocysteine Levels in Stroke Patients Screened for the Vitamin Intervention for Stroke Prevention Clinical Trial in the Era of Folate Fortification

By  

Neuroepidemiology, Vol. 26, Iss. 1, 2005-12 ,pp. : 45-51

Karger

Access to resources Recommend Favorite

Risk and Benefit of Statins in Stroke Secondary Prevention

By  

Current Vascular Pharmacology, Vol. 11, Iss. 6, 2013-11 ,pp. : 812-816

Bentham Science Publishers

Access to resources Recommend Favorite

Risk Factors and Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 10, Iss. 3, 2000-08 ,pp. : 12-21

Karger

Access to resources Recommend Favorite

Clopidogrel in Secondary Ischemic Stroke Prevention

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 119-125

Bentham Science Publishers

Access to resources Recommend Favorite